Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NuCel in Posteriolateral Lumbar Fusions
NCT02070484Terminated
- Sponsor
- OhioHealth
- Start
- Feb 2014
- Primary completion
- Mar 2017
- Modality
- Adult Stem Cells, Tissue Cells
- Countries
- 1
01
Overview
Randomised trial of NuCel in Degenerative Lumbar Disc Disease (DDD), spondylosis and spondylolisthesis (2 arms), sponsored by OhioHealth. Primary endpoint: Oswestry Disability Index at 12 months. Started Feb 2014; status: terminated.
02
Drugs
NuCel
03
Conditions
Degenerative Lumbar Disc Disease (DDD)spondylosisspondylolisthesis
Beyond the preview
Go deeper on NCT02070484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02070484.